VA/DoD 2025 Obesity Guideline Emphasizes Personalized Care and Medication Use

The U.S. Department of Veterans Affairs and the Department of Defense released a revised obesity‑management guideline in 2025, incorporating recent advances in assessment and treatment. The update broadens the evaluation of obesity-related health risks beyond body‑mass index, adding comprehensive risk profiling that includes metabolic, cardiovascular, and psychosocial factors.

The guideline establishes comprehensive lifestyle intervention—dietary counseling, physical activity, and behavioral support—as the core of care. It also permits the flexible use of pharmacologic agents, notably glucagon‑like peptide‑1 (GLP‑1) receptor agonists, and outlines criteria for endoscopic and surgical procedures when lifestyle measures alone are insufficient.

By integrating these evidence‑based strategies, the VA/DoD aims to improve weight‑management outcomes for veterans and service members, providing a clearer framework for clinicians to tailor interventions to individual risk profiles and treatment preferences.